Literature DB >> 23518224

Region-specific diversity of striosomes in the mouse striatum revealed by the differential immunoreactivities for mu-opioid receptor, substance P, and enkephalin.

K Tajima1, T Fukuda.   

Abstract

The complexity of the internal structure of the striatum is not completely understood, and the striosomes/matrix compartmentalization in particular has been one of the intriguing substructures of the striatum. Although various neurochemical markers have been used to visualize striosomes with sufficient clarity, it still remains obscure whether striosomes that are detectable by a single marker represent all of the striosomal compartments and to what extent the compartments are uniform across different intrastriatal positions. Triple immunohistochemical labeling for the three representative striosomes/matrix markers, μ-opioid receptor (MOR), substance P (SP), and enkephalin (Enk), was applied to serial sections covering the whole striatum of the mouse (n=8). The majority of MOR-positive striosomes were confined to the rostral quarter of the striatum. In contrast, SP-positive striosomes were distributed more broadly in the rostral two-thirds of the striatum. No striosomes were observable in the caudal third by the present method. In the rostral striatum, the majority of striosomes were labeled for both MOR and SP, but some at the most rostral positions were detectable only by MOR, while caudally located striosomes were identifiable only by SP. Thus MOR- and SP-immunoreactivities in striosomes exhibited contrasting patterns along the rostrocaudal axis. The Enk immunohistochemistry produced complicated profiles and was unsuitable for the detection of striosomes in mice. However, Enk immunoreactivity in MOR and/or SP-positive striosomes was higher in the ventral portion than in the dorsal portion in the rostral striatum. The present study revealed the region-specific diversity of striosomes, suggesting site-dependent differential regulation of striosomal neurons by MOR ligands and SP that are contained in indirect- and direct-pathway neurons, respectively. The results further suggest the necessity of viewing the striosomes as non-uniform compartments in addition to the traditional dichotomous view, which focuses on discrimination between the striosomes and the matrix.
Copyright © 2013 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23518224     DOI: 10.1016/j.neuroscience.2013.03.012

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  11 in total

1.  Two-photon imaging in mice shows striosomes and matrix have overlapping but differential reinforcement-related responses.

Authors:  Bernard Bloem; Rafiq Huda; Mriganka Sur; Ann M Graybiel
Journal:  Elife       Date:  2017-12-18       Impact factor: 8.140

2.  Enkephalin Disinhibits Mu Opioid Receptor-Rich Striatal Patches via Delta Opioid Receptors.

Authors:  Matthew Ryan Banghart; Shay Quentin Neufeld; Nicole Christine Wong; Bernardo Luis Sabatini
Journal:  Neuron       Date:  2015-12-06       Impact factor: 17.173

3.  Dopamine D₄ receptor counteracts morphine-induced changes in µ opioid receptor signaling in the striosomes of the rat caudate putamen.

Authors:  Diana Suárez-Boomgaard; Belén Gago; Alejandra Valderrama-Carvajal; Ruth Roales-Buján; Kathleen Van Craenenbroeck; Jolien Duchou; Dasiel O Borroto-Escuela; José Medina-Luque; Adelaida de la Calle; Kjell Fuxe; Alicia Rivera
Journal:  Int J Mol Sci       Date:  2014-01-21       Impact factor: 5.923

4.  The cannabinoid-1 receptor is abundantly expressed in striatal striosomes and striosome-dendron bouquets of the substantia nigra.

Authors:  Margaret I Davis; Jill R Crittenden; Austin Y Feng; David A Kupferschmidt; Alipi Naydenov; Nephi Stella; Ann M Graybiel; David M Lovinger
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

Review 5.  Opioidergic Modulation of Striatal Circuits, Implications in Parkinson's Disease and Levodopa Induced Dyskinesia.

Authors:  Stefania Sgroi; Raffaella Tonini
Journal:  Front Neurol       Date:  2018-07-05       Impact factor: 4.003

6.  Selective ablation of striatal striosomes produces the deregulation of dopamine nigrostriatal pathway.

Authors:  Kirill Shumilov; M Ángeles Real; Alejandra Valderrama-Carvajal; Alicia Rivera
Journal:  PLoS One       Date:  2018-08-29       Impact factor: 3.240

7.  Three divisions of the mouse caudal striatum differ in the proportions of dopamine D1 and D2 receptor-expressing cells, distribution of dopaminergic axons, and composition of cholinergic and GABAergic interneurons.

Authors:  Yuta Miyamoto; Issei Nagayoshi; Akinori Nishi; Takaichi Fukuda
Journal:  Brain Struct Funct       Date:  2019-08-02       Impact factor: 3.270

8.  Spatiotemporal Up-Regulation of Mu Opioid Receptor 1 in Striatum of Mouse Model of Huntington's Disease Differentially Affecting Caudal and Striosomal Regions.

Authors:  Ryoma Morigaki; Jannifer H Lee; Tomoko Yoshida; Christian Wüthrich; Dan Hu; Jill R Crittenden; Alexander Friedman; Yasuo Kubota; Ann M Graybiel
Journal:  Front Neuroanat       Date:  2020-12-10       Impact factor: 3.856

9.  Striosome-based map of the mouse striatum that is conformable to both cortical afferent topography and uneven distributions of dopamine D1 and D2 receptor-expressing cells.

Authors:  Yuta Miyamoto; Sachiko Katayama; Naoki Shigematsu; Akinori Nishi; Takaichi Fukuda
Journal:  Brain Struct Funct       Date:  2018-09-10       Impact factor: 3.270

10.  Nuclear Receptor Nr4a1 Regulates Striatal Striosome Development and Dopamine D1 Receptor Signaling.

Authors:  Maria-Daniela Cirnaru; Chiara Melis; Tomas Fanutza; Swati Naphade; Kizito-Tshitoko Tshilenge; Brian S Muntean; Kirill A Martemyanov; Joshua L Plotkin; Lisa M Ellerby; Michelle E Ehrlich
Journal:  eNeuro       Date:  2019-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.